Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis-2027


Posted August 28, 2020 by SANJAYCMI

“Coherent Market Insights “HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027″
 
Medication Management System Market by Software (Inventory Management Solutions, Computerized Physician Order Entry, Clinical Decision Support System Solutions, and Electronic Medication Administration Record), by Mode of Delivery (Location Based Delivery, Web-based Delivery, and Cloud-based Delivery), by End User (Hospitals, Retail Pharmacies, and Home based care), and by Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2026

Medication management system involves the use of different IT based services by retail pharmacies or hospitals to provide right dose torightpatient at right time. Medication management system is becoming an essential part of pharmacies across the globe to improve operational efficiency by avoiding situation of overstocking, understocking, increased drug cost, drug adversity, and dispensing error. This is done by utilizing automated software and robotics system, which aids in inventory management, efficient dispensing of medication and better patient tracking thereby improving productivity. Medication management system plays an important role in management of data, as number of complex therapies is increasing in clinical practice along with increasing length of prescriptions, and lack of structured decision making for selecting drug and doses. Physicians and nurses are facing complexity in their area of function such as large patient pool with requirement of chronic therapy, which can be eased with the help of medication management system. Managing bunch of information right from patient data, regulatory compliance to product related data is made easy due to medication management system.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/medication-management-system-market-1287

Increasing medication error and pool of geriatric patient to drive growth of the medication management system market worldwide

According to the World Health Organization (WHO) report in 2017, medication error costs US$ 42 billion annually worldwide. This figures suggest increasing demand for medication management system as essential part of an overall healthcare infrastructure. As per the World Population Prospect, 2017, Revision report by United Nations, in 2017, around 962 million people under geriatric category, which would demand for rising primary healthcare and long term care. This population is likely to face adverse drug event due to likely chance of error made by them in administering medicine, which can be minimized by using medication management system. This would propel the growth for the global medication management system. According to WHO Factsheet, by 2020, about 73% of global deaths would be from chronic disease such as cancer, cardiovascular disease or diabetes, which requires long term medication with efficient medication dispensing and continuous patient monitoring, which can be done effectively through medication management system. According to the report published by International Pharmaceutical Federation in 2017, among 74 surveyed economies, 55.73% of prescription medicines are sold through hospital pharmacy. Increased use of IT technology for operational efficiency, lack of trained pharmacist and nurses is expected to boost growth of the medication management system market.

North America is expected to hold the dominant position in medication management system market due presence of healthcare IT infrastructure, high incidence, and prevalence of chronic disease and high per capita expenditure

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1287

North America and especially U.S. is expected to hold the dominant position in the medication management system market, owing to the high prevalence of chronic disease in the U.S. According to Centre for Disease Control and Prevention (CDC) review in 2017, seven out of ten death were from chronic disease in 2014. Also, in 2012, the U.S. had 117 million population with one or more chronic disease. Thus presence of population with chronic disease would need efficient medication management, which would propel growth of the medication management system market. The Agency for Healthcare Research and Quality reported that in 2015, there were 41.4 adverse drug events per 1000 population especially in therapies, which can be reduced by utilizing medication management system. Health infrastructure in the U.S. is also increasingly using IT based services to better manage patient pool. There is expected to be shortage of nurses and physicians in near future, according to study in 2017 by Association of American Medical Colleges, U.S. would have a shortage of between 40,800 and 104,900 physicians by 2030, which would create need to adopt medication management system.

Key Players are consolidating their market position through mergers and acquisition and new product launches

In 2015, Becton, Dickinson and Company completed the acquisition of CareFusion Corporation at US$ 12.2 billion. CareFusion Corporation is specialized in reducing medication error. This acquisition would provide scale and depth to Becton and Dickinson and Company in medication management and patient safety solution.

In August 2017, Swisslog Healthcare announced acquisition of Talyst, Swisslog Healthcare is leading company in medication and supply chain services and solutions. Talyst is market leader in pharmacy automation solutions for hospitals and long term care facilities. In November 2017, Swisslog Healthcare launched cloud-based data analytics platform called Pharmacy Analytics, which is designed to help hospital pharmacies to improve operational efficiencies.

In August 2017, Allscripts announced to acquire McKesson Corporation’s hospital and health system IT business and Enterprise Information Solutions for US$ 185 million in cash.

In December 2017, Becton, Dickinson and Company launched BD ‘HealthSight’ platform, a comprehensive medication management for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1287

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags hematopoietic stem cell transplantation hsct market growth , hematopoietic stem cell transplantation hsct market share , hematopoietic stem cell transplantation hsct market size
Last Updated August 28, 2020